Zydus Research Centre, Sarkhej-Bavla N.H. 8A, Moraiya, Ahmedabad 382 210, India.
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5701-6. doi: 10.1016/j.bmcl.2011.08.031. Epub 2011 Aug 11.
Two novel series of 5-nitro-2-phenoxybenzoic acid derivatives are designed as potent PAI-1 inhibitors using hybridization and conformational restriction strategy in the tiplaxtinin and piperazine chemo types. The lead compounds 5a, 6c, and 6e exhibited potent PAI-1 inhibitory activity and favorable oral bioavailability in the rodents.
设计了两个新型的 5-硝基-2-苯氧基苯甲酸衍生物系列,作为潜在的 PAI-1 抑制剂,采用了 tiplaxtinin 和哌嗪类化合物的杂交和构象限制策略。先导化合物 5a、6c 和 6e 在啮齿动物中表现出很强的 PAI-1 抑制活性和良好的口服生物利用度。